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Stlml'l'llSry 
The costimulatory signal provided to T cells through CTLA-4-1igand  interactions  is required 
for T cell activation resulting in increased interleukin 2 (IL-2) production in vitro, but its role 
in the production of 1I.-4 and other cytokines is unclear and few in vivo studies have  been performed 
to confirm results of in vitro experiments.  We have examined the in vivo effects of blocking 
CTLA-4 ligands on the T helper cell 2 (Th2)-associated mucosal immune response that follows 
oral  infection  of mice with  the  nematode parasite, Heligmosorao!des polygyrus.  CTLA-4Ig 
administration  inhibited H. polygyrus-induced increases in mesenteric lymph node (MLN) B cell 
major histocompatibility complex dams  II expression  and size and T cell-derived IL-4 gene expression. 
In addition, CTLA-4 immunoglobulin (Ig) partially blocked increased  IL-3, IL-5, and IL-9 cytokine 
gene expression in Peyer's patch (PP) and MLN 8 d after primary inoculation of mice with the 
parasite. Increases in the number of IL-4- but not IL-5-secreting cells were also inhibited by 
CTLA-4Ig. H. polygyrus-induced elevations in serum IgE levels but not blood eosinophils, were 
markedly inhibited by CTLA-4Ig. These results suggest that stimulation of  CD28 and/or CTLA-4 
is required for T cell priming leading to IL-4 cytokine production, B cell activation,  and IgE 
secretion during a Th2-1ike, mucosal immune response to a nematode parasite. 
D 
uring the primary in vivo immune response, CD4 § T 
cells use the CD3-associated  TCK-ot//~  complex to 
recognize Ag bound to self-class II MHC on the surface of 
the APC. In addition to signals through the TCR, costimula- 
tory signals are also required for T cell activation. The inter- 
action of B7 (both B7-1 and B7-2) on APCs with CD28 
on T cells has been found to be necessary for T cell activation 
leading to IL-2 production in vitro (1-4).  In vitro studies 
have demonstrated that, in the absence of exogenous IL-2, 
Thl clones and fresh T cells require CD28 signaling in addi- 
tion to TCR signaling for activation and IL-2 production 
(5, 6), and that in the absence of such costimulation, Thl 
cells are anergized (7). In contrast, some Th2 clones produce 
IL-4 upon engagement of the TCK, but are not responsive 
to IL-4 unless provided with costimulatory signals, in par- 
ticular IL-1 (8-10) or CD28 (11). Furthermore, CTLA-4Ig 
inhibits  alloantigen-specific responses and IL-2 and IFN-3, 
gene expression in MLCs but increased IL-4 gene expression 
and some proliferation  persist (12). 
These findings suggest that CTLA-4-1igand  interactions 
may be required for IL-2 production in vitro but that differen- 
tiation towards  IL-4 production may be induced by other 
costimulatory signals. In this study, we have examined the 
role of the CTLA-4 ligand costimulatory pathway in priming 
for T cell IL-4 production during an in vivo Th2-1ike im- 
mune response to the nematode parasite, Heligmosomoides  poly- 
gyms.  This parasite has a strictly enteral life cycle in which 
infective third-stage larvae invade the intestinal mucosa <24 h 
after ingestion and develop there into mature adults (13). The 
resulting mucosal immune response is associated with eleva- 
tions in CD4 + T cell IL-4 gene expression and protein secre- 
tion, T cell-dependent and -independent elevations in IL-3, 
IL-5, and IL-9 mRNA, eosinophilia, and also a vigorous B 
cell response resulting in marked increases in serum IgE (13, 
14,  and our unpublished  results). 
Our results show that CTLA-4Ig profoundly inhibits IL-4 
gene expression and IL-4 secretion, B cell size, surface MHC 
class II expression, and serum IgE levels, and document the 
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and B cell primary in vivo response to this enteric pathogen. 
In contrast,  cytokine production by non-T ceils, in partic- 
ular IL-5, is still elevated and can support the development 
of eosinophilia in the absence of CTLA-4-1igand-mediated 
T  cell activation. 
Materials  and Methods 
Animals.  BALB/c female mice were purchased from the Small 
Animal  Division  of the  National  Institutes  of Health  ([NIH] 
Bethesda,  MD) and were used at age 8-12 wk. The experiments 
herein were conducted according to the principles  set forth in the 
Guide for the Care and Use of Laboratory Animals,  Institute of 
Animal Resources,  National Research Council,  Department  of 
Health, Education and Welfare (NIH) 78-23. 
Ahs.  Abs and reagents used include mouse CTLA-4Ig fusion 
protein produced and purified as described previously (15, 15a), and 
purified human-mouse chimeric mAb L6, a gift of Ingegerd and 
Karl Eric Hellstrom (Bristol-Myers Squibb Pharmaceutical Research 
Institute). For FACS  |  analysis (Becton Dickinson, Mountain View, 
CA),  we used the anti-MHC  class II (MKD6)  (16),  anti-CD4 
(GK1.5) (17), anti-TCR-ce/~ (Pharmingen, San Diego, CA), and 
anti-B220 (6B2) Abs, and for the ELISPOT we used a pair of anti- 
IL-4 Abs (BVD41D112 and BVD6.24G2.3 [18]) and a pair of anti- 
IL-5 Abs  (TRFK-4 and TRFK-5 [19]). 
ParasitologicalParameters.  Infective, ensheathed third-stage larvae 
of  H. polygyrus (specimens on file at the U.S. National Parasite Col- 
lection, U.S. National Museum Helminthotogical Collection, U.S. 
National Museum Helminthological Collection no. 81930, Belts- 
ville, ME)) were propagated and stored at 4~  until used.  Mice 
were inoculated orally with 200 larvae using a ball-tipped feeding 
tube (14). 
Treatment with CTLA-4Ig Fusion Protein.  After H. polygyrus in- 
ocuhtion, mice were injected intravenously via the tail vein on days 
0 and 1 with 100/~g routine CTLA-4Ig or the control fusion pro- 
tein L6. 
CellLabeling and Analysis.  Mesenteric lymph node (MLN) cells 
were washed and then stained with appropriate dilutions of FITC- 
anti-MHC class II antibodies and biotinylated anti-B220 Abs fol- 
lowed by PE-avidin as previously described (20). Dual-color flow 
cytometric analysis and sorting was accomplished with an Epics 
Elite flow cytometer (Coulter Electronics, Miami, FL). An argon 
laser was used as the excitation source for both FITC and PE. Sorted 
CD4 +, TCR-cr  + cells were >97%  pure. 
Quantitation of  Serum Ig and Eosinophil Counts.  Serum IgE levels 
were determined by a micro ELISA (21). Eosinophils were counted 
from fresh blood samples with the Unopette Test (Becton Dick- 
inson, Rutherford, NJ). 
ELIBPO'E.  The frequency oflL-4- and Ib5-produdng cells was 
determined by an ELISPOT assay as previously described (22). The 
anticytokine "capture" Abs that were bound to the polystyrene plates 
were either BV41D112 for II-4 or TRFK-5 for I~5. The biotinylated 
anticytokine Abs which were used to bind cytokine antigen cap- 
tured from cytokine-secreting cells by the plate-bound Ab were 
BVD6.24G2.3 for II-4 and TRFK-4 for IL-5. 
RT-PCR.  The coupled ILT-PCR reaction was used as previously 
described to quantitate differences in cytokine gene expression be- 
tween treatment groups (20,  23). 
Resu|ts 
CTLA-4Ig Inhibits H. polygyrus-induced Cytokine Gene Ex- 
pression.  Previous studies have shown that an early T-inde- 
pendent increase in IL-3, IL-5, and IL-9 mRNA  occurs in 
the Peyer's patch (PP) during the first several days after H. poly- 
gyrus inoculation. By day 6, elevations in these three cytokines 
are at least partly T cell dependent. IL-4 gene expression and 
protein secretion are, in contrast, first elevated at 6-8 d after 
inoculation.  Cell sorting analyses have shown that the pri- 
mary source (>99%) of IL-4 mRNA  elevation and protein 
secretion is  CD4 +,  TCRc~/~ +  cells  (14,  and  our unpub- 
lished data). 
To determine whether blocking CTLA-4 ligands could in- 
hibit increases in Th2-associated cytokines, mice were injected 
with 100 #g i.v. of either murine CTLA-4Ig or the control 
fusion protein L6 at days 0 and 1 after oral inoculation with 
200 third-stage H. polygyrus larvae. 8 d after inoculation, PP 
and MLN were removed from mice (five per group) and in- 
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Figure  1.  CTLA-41g  administration inhibits elevations  in I1.,4 and IL-9 
and partially inhibits devations in II.,3 and II.-5 in the Peyer's  patch (PP) 
and inhibits elevations in Ib4 and Ib3, but not in IL-5 in the mesenteric 
lymph node (MLN) at day 8 after H. polygyrus inoculation. IFN-y was 
not consistently devated in this response and Ib9 was not consistently 
elevated in the MLN. CTLA-4-Ig (100/~g) or the control fusion protein 
(L6) (100/~g) was administered at days  0 and I after oral inoculation with 
200 third-stage larvae. Tissues were collected at day 8 after inoculation 
and cytokine gene expression  levels  were determined  by a quantitative RT- 
PCR. The mean and SE derived  from PP or MLN of  five  individual  BALB/c 
mice are shown for each treatment group. All data were individually nor- 
malized to the endogenous internal standard, HPRT, which did not show 
greater then two- to threefold changes throughout the experiment. The 
means are expressed  relative  to the mean of the uninfected control, which 
was arbitrarily given a value of 1. Similar results were obtained in two 
independent experiments. 
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blocked IL-4 elevations in both the PP and the MLN (Fig. 
1). Increases in IL-3 were completely blocked by CTLA-4Ig 
in the MLN and partially blocked in the PP whereas increases 
in IL-5 were partially blocked in both the PP and the MLN. 
IL-9, which increases  in PP but usually not MLN, was in- 
hibited by CTLA-4Ig. IFN-'y was not elevated in either the 
PP or the MLN ofH. t~olygyrus-inoculated  mice and was not 
affected by CTLA4-Ig. 
Blocking  CTLA-4  Ligands Completely Suppresses H. 
polygyrus-induced Increases in 1I.-4- but not IL-5-secreting  MLN 
Cells.  The complete inhibition of H. polygyrus-induced IL-4, 
but not IL-5 gene expression by CTLA4-Ig suggested that 
CTLA4-Ig might have similar effects on cytokine secretion. 
ELISPOT assays were used to examine this possibility. The 
number of IL-4-secreting cells/106 MLN cells was markedly 
elevated at 8 d after H. polygyrus inoculation of mice given 
control L6. CTLA-4Ig treatment of H. polygyrus-inoculated 
mice inhibited  the number of IL-4-secreting cells to levels 
close to those of uninfected mice (Fig.  2). Similarly,  sorted 
CD4 +, TCR-c~/3 + cells from H. polygyrus-inoculated mice 
given  L6  showed marked  increases  in  IL-4-secreting  cells 
whereas  almost  complete  inhibition  occurred  in  CD4 § 
TCR-od3 + cells  from H. polygyrus-inoculated mice given 
CTLA-4Ig  (data not shown).  Although a marked increase 
in IL-5-secreting cells was also detected in the MLN of H. 
polygyrus-inoculated mice, blocking CTLA-4 ligands did not 
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Figure 2.  Elevations  in the number of IL-4- but not Ib5-secreting cells 
from the MLN ofH. polgyrus-inocuhted  mice are blocked  by CTLA-4-1g 
administration. CTLA-4Ig treatment and H. polygyrus  inoculation are as 
described in Fig. 1. The numbers of IL-4- and IbS-secreting cells/10~ 
MLN cells  were determined in an ELISPOT assay  without restimulation. 
The mean and SE derived from PP of five individual BALB/c mice are 
shown for each treatment group. 
decrease the number of IL-5-secreting cells (Fig. 2) consis- 
tent with the less than twofold inhibition by CTLA-4Ig of 
IL-5 cytokine gene expression in H. polygyrus-inoculated  mice. 
Cell sorting showed that the major source of the IL-5-secreting 
cells in H. polygyrus-inoculated mice was CD4-  cells (data 
not  shown). 
CTLA-4Ig Blocked Serum IgE Elevations and Partially Sup- 
pressed Blood Eosinophil Counts.  The decreases  observed in 
both IL-4 gene expression and secretion suggested that IgE 
production, which is IL-4 dependent (24), might be reduced 
by blocking CTLA-4 ligands during the H. polygyrus  response. 
Because circulating  IgE levels  are not consistently elevated 
until 2 wk after H, polygyrus inoculation, an independent ex- 
periment was performed in which sera were collected at that 
time. Mice administered L6 on the day of and one day after 
H. polygyrus inoculation showed marked increases  in serum 
IgE whereas IgE levels in H. polygyrus-inoculated mice treated 
with CTLA-4Ig at the same time points were only slightly 
greater than those of untreated control mice (Fig. 3). In the 
same experiment, the H. polygyrus-induced increase in blood 
eosinophil counts was, like the increase in PP and MLN IL-5 
gene expression, only partially inhibited by CTLA4-Ig treat- 
ment  (Fig.  3). 
B Cell Activation Is Blocked by Administration of CTLA-4Ig 
Fusion Protein.  The inhibition of serum IgE levels 14 d after 
H. polygyrus inoculation  suggested that  blocking CTLA-4 
ligands may affect B cell activation or differentiation to Ig- 
secreting cells.  To examine whether B cells were activated 
in H. polygyrus-inoculated, CTLA-4Ig-treated  mice,  MLN 
cell suspensions from these mice were stained simultaneously 
with anti-MHC class II and B cell-specific anti-B220 (6B2). 
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Figure 3.  Blocking  CTLA-4 ligands inhibits elevations in serum IgE 
levels  but only partially inhibits blood eosinophil elevations  at day 14 after 
H. polygFus  inoculation. CTLA-4Ig treatment and H. polygyrus  inocula- 
tion are as described  in Fig. 1. Mice  were bled at day 14 after inoculation 
and serum IgE levels and blood eosinophil counts were determined. 
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gands during the immune  response 
to H. ~lygFus. CTLA-4-Ig (100/~g) 
or the control fusion protein (L6) 
was administered at days 0 and 1 
after oral inocuhtion  with 200 third- 
stage H. polygFus  hrv~ MLN tissue 
was collected at day 8 after inocula- 
tion and cell suspensions from five 
individual BALB/c mice per treat- 
ment group were pooled and dual 
stained with FITC-anti-MHC  class 
II and biotinylated anti-B220 (6B2) 
followed by PE-avidin. Single histo- 
gram analyses of B  cell (B220  +) 
MHC class II expression  and cell size 
are shown. 
MHC class II expression and forward light scatter (a corre- 
late of cell size) on B220 + cells was markedly increased in 
H. polygyrus-inoculated mice administered L6, whereas H. 
polygyrus-inoculated mice given CTLA-4Ig showed MHC 
class II and forward light scatter profiles similar to B cells 
from untreated mice (Fig.  4). 
Discussion 
This investigation demonstrates that CTLA-4 ligands play 
a key role in the development of the Th2-1ike enteric im- 
mune response to the nematode parasite, H. polygyrus. This 
vigorous immune response is restricted to the enteric region 
and is characterized by marked elevations in both serum IgE 
and blood eosinophils (24) and elevations in IL-3, IL-4, IL-5, 
and IL-9 gene expression (14). Elevations in IL-4 are derived 
from CD4 + T  cells and elevations in IL-3,  IL-5, and IL-9 
are at least partially T cell independent (14). Our studies show 
that administration of CTLA-4Ig at early stages of the infec- 
tion inhibits development of both the T and B cell responses, 
but only partially inhibits eosinophilia. 
Previous studies have not been performed on the role of 
CTLA-4 ligands in the development of an IL-4-dominant 
in vivo immune response. However, in vitro studies have sug- 
gested that Th2 cells can utilize costimulatory signals be- 
sides CD28,  in particular IL-1  (8-10,  25).  McArthur and 
Raulet (11) have shown that either IL-1 or CD28 can serve 
as costimulatory signals mediating responsiveness to IL-4 in 
Th2 clones, but that CD28 is not required for IL-4 produc- 
tion. Our studies extend these findings to an in vivo model 
where IL-4 is produced in the early stages of a primary re- 
sponse by T  cells in the absence of increased IL-2 gene ex- 
pression (14). Our findings show that CTLA-4-1igand in- 
teractions are necessary for elevations in IL-4 gene expression 
and IL-4 production in this system and suggest that other 
costimulatory signals, such as IL-1,  the heat stable antigen 
(26),  or LFA-1 and CD2 (27,  28),  are either not available 
or cannot substitute for CTLA-4-1igand interactions. 
In contrast to our observations, mice transgenic for soluble 
murine CTLA-4-Hyl exhibit normal T  cell priming and 
cytokine production after  immunization with  a  T  cell- 
dependent antigen (29, 30). One possible reason for this differ- 
ence  from our  results  is  that  these transgenic mice lack 
CD28/CTLA-4 costimulatory signals from birth and may 
have compensated during ontogeny by using other signals. 
Alternatively, mCTLA-4-H'y1 may not be produced at suffi- 
cient levels to block CTLA-4-1igand interactions required for 
the induction of T cell responses. Our results clearly show 
that blocking CTLA-4 ligands by administration of CTLA- 
4Ig in normal mature animals completely inhibits elevations 
in T cell-derived cytokine gene expression and IL-4 protein 
secretion. Consistent with this observation, we have also ob- 
served that T cell cytokine production is blocked in the spleen 
of goat anti-mouse IgD-immunized mice treated with CTLA- 
4Ig  (Lu,  P.,  X.  Zhou,  S.  J.  Chen,  M.  Moorman,  A. 
Sconcvr  S.  Morris,  F.  D.  Finkelman,  P.  Linsley,  E. 
Claassen, and W. C. Gause, manuscript submitted for publi- 
cation). 
Although high circulating IgE levels are detected 14 d after 
H. polygyrus inoculation, CTLA-4Ig administration at day 
0 and 1 after inoculation strongly inhibited serum IgE levels. 
Previous studies (29-31) have also demonstrated CTLA-4Ig 
inhibition of a primary in vivo antibody response. Our fur- 
ther observation that increases in B cell size and MHC class 
II expression are blocked by CTLA-4Ig administration is con- 
sistent with a requirement for T cell help for B cell activa- 
tion during this in vivo mucosal response. Cytokine produc- 
tion by non-T cells and costimulatory signals provided to 
B cells by mast cells and basophils expressing gp39 (32) are 
either themselves T cell dependent or cannot substitute for 
the Th cell stimulation that is mediated by CTLA-4-1igand 
interactions. In contrast, our finding that blocking CTLA- 
4-1igand interactions only partially inhibited elevations in IL-5 
gene expression and blood eosinophilia suggests partial T cell 
independence of these responses and is consistent with the 
prior observations that anti-CD4 mAb only partially inhibits 
blood eosinophilia (Urban, J.  F., unpublished data). 
Studies from in vitro systems have suggested that IL-2 may 
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CTLA-4 ligands, in the absence of exogenous IL-2, may in- 
hibit IL-4 production by initially blocking IL-2 production 
(35). However, IL-2 gene knockout mice have been shown 
to have constitutively high levels of IgG1, which is at least 
partially IL-4 dependent, and to make in vivo T ceU-depen- 
dent immune responses to some pathogens that are comparable 
to those of control mice, suggesting that IL-2 is not required 
for in vivo T  cell-mediated immune responses (36, 37).  It 
is also unlikely that IL-2 plays a major role in the H. poly- 
gyms system since no increase is detected in IL-2 gene expres- 
sion in the PP or the MLN during the course of the response 
to H. polygyrus  (14) and administration  of anti-IL-2 Abs to 
H. polygyrus-infected mice does not affect serum IgE produc- 
tion (Finkelman, F. D., and J. F. Urban, unpublished obser- 
vations), although the same anti-IL-2 Abs block immune re- 
sponses  in  another  system  (38).  Thus,  we believe that  a 
CTLA-4-1igand interaction is important for the generation 
of an IL-4 response even in an IL-2-independent  system. 
Our findings are also important from a therapeutic view- 
point since they suggest that the T cell development pathway 
leading to IL-4 production in the mucosal region can be in- 
hibited by blocking CTLA-4-1igand interactions.  One poten- 
tial therapeutic approach relies on the premise that blocking 
CTLA-4-1igand interactions during an immune response to 
an allergen  or other antigen might induce tolerance,  resulting 
in unresponsiveness to subsequent challenges.  Our findings 
that the primary T cell response to H. polygyrus is dependent 
on B7 costimulation suggest an experimental in vivo model 
for future studies directed towards determining  whether T 
cell  anergy  will  occur in  the  absence of CTLA-4-1igand 
costimulatory signals during  a Th2-1ike response. 
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